Tudor Investment Corp ET AL Takes $7.58 Million Position in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Tudor Investment Corp ET AL opened a new stake in Sabra Healthcare REIT, buying 406,413 shares valued at about $7.58 million, representing roughly 0.16% of the company.
• Sabra missed quarterly EPS expectations, reporting $0.11 versus the $0.37 consensus while revenue rose to $201.35 million (up 16.2% year-over-year), and the company set FY2026 guidance at 1.55–1.59 EPS.
• Sabra pays a quarterly dividend of $0.30 (annualized $1.20) equating to a ~6.1% yield, but the dividend payout ratio is a high 187.5%.

Tudor Investment Corp ET AL bought a new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 406,413 shares of the real estate investment trust's stock, valued at approximately $7,576,000. Tudor Investment Corp ET AL owned 0.16% of Sabra Healthcare REIT at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Founders Capital Management acquired a new position in shares of Sabra Healthcare REIT in the 3rd quarter valued at $28,000. Danske Bank A S bought a new stake in Sabra Healthcare REIT in the third quarter valued at about $30,000. Larson Financial Group LLC raised its position in Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust's stock worth $35,000 after purchasing an additional 553 shares in the last quarter. Covestor Ltd raised its position in Sabra Healthcare REIT by 23,720.0% in the third quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust's stock worth $45,000 after purchasing an additional 2,372 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its stake in Sabra Healthcare REIT by 150.7% during the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust's stock worth $47,000 after purchasing an additional 1,536 shares during the period. Institutional investors and hedge funds own 99.40% of the company's stock.

Analyst Ratings Changes

SBRA has been the topic of several analyst reports. Scotiabank upped their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "sector perform" rating in a research note on Monday, March 2nd. Citizens Jmp raised their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a "market outperform" rating in a research report on Wednesday, February 18th. Jefferies Financial Group reaffirmed a "buy" rating and issued a $22.00 price target on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. Cantor Fitzgerald upped their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "neutral" rating in a research report on Tuesday, February 17th. Finally, UBS Group increased their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a "neutral" rating in a research note on Thursday, February 19th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $21.90.

Sabra Healthcare REIT Trading Up 0.5%

SBRA opened at $19.69 on Tuesday. Sabra Healthcare REIT, Inc. has a 1-year low of $15.75 and a 1-year high of $21.07. The stock has a market capitalization of $4.96 billion, a PE ratio of 30.77, a PEG ratio of 1.56 and a beta of 0.64. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90. The firm has a 50-day moving average price of $19.76 and a two-hundred day moving average price of $19.06.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.37 by ($0.26). Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The company had revenue of $201.35 million for the quarter, compared to analyst estimates of $201.97 million. During the same quarter in the previous year, the company posted $0.36 earnings per share. Sabra Healthcare REIT's revenue for the quarter was up 16.2% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Shareholders of record on Friday, February 13th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.20 annualized dividend and a yield of 6.1%. Sabra Healthcare REIT's dividend payout ratio is currently 187.50%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc NASDAQ: SBRA is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra's tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.